Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07511361 · ClinicalTrials.gov registry record · Phase 2
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
A Phase 2 study, sponsored by Kardigan.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT07511361 is a Phase 2 study that is actively recruiting participants, run by Kardigan. The registered enrollment target is 140 participants.
The verdict
NCT07511361, a Phase 2 study, is actively recruiting participants, sponsored by Kardigan.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Interventions
- DRUG Placebo
- DRUG Tonlamarsen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2027-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07511361
The ClinicalTrials.gov registry entry for NCT07511361 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kardigan, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07511361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07511361 about?
NCT07511361 is a clinical study titled "Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension". The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
What is the current status of trial NCT07511361?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2026-06-23. Estimated completion is 2027-02.
What interventions are being tested in trial NCT07511361?
The interventions under investigation include: Placebo (DRUG), Tonlamarsen (DRUG).
Who is sponsoring clinical trial NCT07511361?
This trial is sponsored by Kardigan, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.